Autologous mRNA cancer vaccine (neoantigen vaccine)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous mRNA cancer vaccine (neoantigen vaccine), covering 2020-04-24 to 2020-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Messenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autologous Cancer [Phase 1, Phase 2]